This inventor holds 1 USPTO granted patent. Top assignee: Repligen Corporation. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovations of Charles D. Moseley
Introduction
Charles D. Moseley is an accomplished inventor based in Arlington, VA. He has made significant contributions to the field of medical therapies, particularly in the treatment of patients with elevated purine levels. His work is especially relevant for individuals diagnosed with pervasive developmental disorders, such as autistic disorder, and neuromuscular disorders.
Latest Patents
Moseley holds a patent for his invention titled "Uridine therapy for patients with elevated purine levels." This innovative therapy is based on the discovery that uridine compositions can effectively treat patients suffering from elevated purine levels. His research has the potential to improve the quality of life for many individuals facing these challenging health issues. He has 1 patent to his name.
Career Highlights
Charles D. Moseley is currently employed at Repligen Corporation, where he continues to advance his research and development efforts. His work at Repligen Corporation has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his innovations.
Collaborations
Moseley has worked alongside notable colleagues, including Theodore M. Page and Deborah Brewer. Their combined expertise has contributed to the success of various projects and initiatives within the company.
Conclusion
Charles D. Moseley is a pioneering inventor whose work in uridine therapy represents a significant advancement in medical treatment for patients with elevated purine levels. His contributions continue to shape the future of therapeutic interventions in this area.